210 related articles for article (PubMed ID: 37949118)
1. Brain cholesterol homeostasis and its association with neurodegenerative diseases.
Gao Y; Ye S; Tang Y; Tong W; Sun S
Neurochem Int; 2023 Dec; 171():105635. PubMed ID: 37949118
[TBL] [Abstract][Full Text] [Related]
2. Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders.
Turri M; Marchi C; Adorni MP; Calabresi L; Zimetti F
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 May; 1867(5):159123. PubMed ID: 35151900
[TBL] [Abstract][Full Text] [Related]
3. LXR Regulation of Brain Cholesterol: From Development to Disease.
Courtney R; Landreth GE
Trends Endocrinol Metab; 2016 Jun; 27(6):404-414. PubMed ID: 27113081
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol metabolism and homeostasis in the brain.
Zhang J; Liu Q
Protein Cell; 2015 Apr; 6(4):254-64. PubMed ID: 25682154
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases.
Vance JE
Dis Model Mech; 2012 Nov; 5(6):746-55. PubMed ID: 23065638
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.
Dai L; Zou L; Meng L; Qiang G; Yan M; Zhang Z
Mol Neurobiol; 2021 May; 58(5):2183-2201. PubMed ID: 33411241
[TBL] [Abstract][Full Text] [Related]
7. Sterols in the central nervous system.
Mulder M
Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):152-8. PubMed ID: 19202386
[TBL] [Abstract][Full Text] [Related]
8. Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases.
Coisne C; Tilloy S; Monflier E; Wils D; Fenart L; Gosselet F
Molecules; 2016 Dec; 21(12):. PubMed ID: 27999408
[TBL] [Abstract][Full Text] [Related]
9. Revisiting the critical roles of reactive astrocytes in neurodegeneration.
Qian K; Jiang X; Liu ZQ; Zhang J; Fu P; Su Y; Brazhe NA; Liu D; Zhu LQ
Mol Psychiatry; 2023 Jul; 28(7):2697-2706. PubMed ID: 37037874
[TBL] [Abstract][Full Text] [Related]
10. Effects of oxysterols on the blood-brain barrier: implications for Alzheimer's disease.
Gosselet F; Saint-Pol J; Fenart L
Biochem Biophys Res Commun; 2014 Apr; 446(3):687-91. PubMed ID: 24275140
[TBL] [Abstract][Full Text] [Related]
11. The Role of Brain Cholesterol and its Oxidized Products in Alzheimer's Disease.
Giudetti AM; Romano A; Lavecchia AM; Gaetani S
Curr Alzheimer Res; 2016; 13(2):198-205. PubMed ID: 26391039
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system cholesterol metabolism in health and disease.
Ho WY; Hartmann H; Ling SC
IUBMB Life; 2022 Aug; 74(8):826-841. PubMed ID: 35836360
[TBL] [Abstract][Full Text] [Related]
13. Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.
Raha AA; Biswas A; Henderson J; Chakraborty S; Holland A; Friedland RP; Mukaetova-Ladinska E; Zaman S; Raha-Chowdhury R
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162984
[TBL] [Abstract][Full Text] [Related]
14. The role of transferrins and iron-related proteins in brain iron transport: applications to neurological diseases.
Campos-Escamilla C
Adv Protein Chem Struct Biol; 2021; 123():133-162. PubMed ID: 33485481
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list?
Valenza M; Cattaneo E
Prog Neurobiol; 2006 Nov; 80(4):165-76. PubMed ID: 17067733
[TBL] [Abstract][Full Text] [Related]
16. Potential Use of the Cholesterol Transfer Inhibitor U18666A as a Potent Research Tool for the Study of Cholesterol Mechanisms in Neurodegenerative Disorders.
Yasamineh S; Mehrabani FJ; Derafsh E; Danihiel Cosimi R; Forood AMK; Soltani S; Hadi M; Gholizadeh O
Mol Neurobiol; 2024 Jun; 61(6):3503-3527. PubMed ID: 37995080
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System.
Carpanini SM; Torvell M; Morgan BP
Front Immunol; 2019; 10():362. PubMed ID: 30886620
[TBL] [Abstract][Full Text] [Related]
18. Can Astrocytes Be a Target for Precision Medicine?
Allen CF; Shaw PJ; Ferraiuolo L
Adv Exp Med Biol; 2017; 1007():111-128. PubMed ID: 28840555
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol Metabolism in Neurodegenerative Diseases.
He K; Zhao Z; Zhang J; Li D; Wang S; Liu Q
Antioxid Redox Signal; 2024 Jun; ():. PubMed ID: 38842175
[TBL] [Abstract][Full Text] [Related]
20. LXR agonists: new potential therapeutic drug for neurodegenerative diseases.
Xu P; Li D; Tang X; Bao X; Huang J; Tang Y; Yang Y; Xu H; Fan X
Mol Neurobiol; 2013 Dec; 48(3):715-28. PubMed ID: 23625315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
